Everspin Technologies vs NVE
MRAM and NVEC side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MRAM and NVEC compare
NVE is the larger company, worth 1.2 times as much as Everspin Technologies ($407M against $328M).
NVE grew revenue faster over the last twelve months (24.1% versus 20.9% for Everspin Technologies).
NVE keeps more of each dollar of sales as profit, with a net margin of 58.1% compared with −4.2% at Everspin Technologies.
NVE pays a dividend yielding 4.8%; Everspin Technologies does not pay one.
NVE scores higher on the StockData Score (19 against 7 for Everspin Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MRAM | NVEC |
|---|---|---|
| Size and price | ||
| Market cap | $328M | $407M |
| Share price | $13.45 | $83.97 |
| Change, 1 year | 43.4% | 28.3% |
| Change, 5 years | 10.2% | 13.9% |
| Beta (5Y) | 1.72 | 1.05 |
| Employees | 85 | 42 |
| StockData Score | ||
| Total score | 7 | 19 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 6 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 22.8× |
| P/S | 5.2× (better) | 13.2× |
| P/B | 4.5× (better) | 7.0× |
| EV/EBITDA | – | 20.2× |
| P/FCF | – | 21.8× |
| FCF yield | −1.6% | 4.6% (better) |
| Fair value | $10.20 | $82.85 |
| Margin of safety | −31.9% | −1.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 20.9% | 24.1% (better) |
| Revenue growth, 5Y average | 5.6% (better) | 4.3% |
| Net income growth (TTM) | −260% | 29.3% (better) |
| EPS growth (TTM) | −257% | 29.5% (better) |
| EPS growth, 5Y average | – | 5.3% |
| Profitability | ||
| Gross margin | 52.3% | 79.3% (better) |
| Operating margin | −15.5% | 61.6% (better) |
| Net margin | −4.2% | 58.1% (better) |
| FCF margin | −8.6% | 60.7% (better) |
| Return on equity | −3.8% | 30.4% (better) |
| Return on invested capital | −29.6% | 42.7% (better) |
| Financial health | ||
| Debt / equity | 0.01 (better) | 0.00 |
| Current ratio | 4.74 | 29.05 (better) |
| Altman Z-score | 10.92 | 132.57 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | 4.8% (better) |
| Payout ratio | – | 108% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | – | 0.00% |
| Shareholder yield | 0.00% | 4.8% (better) |
| Ownership | ||
| Held by institutions | 52.4% | 92.0% |
| Held by insiders | 7.3% | 0.85% |
| Insider net buying, 12 months | −$19.8M | −$5.3M (better) |
| Short interest, % of float | 14.5% | 13.0% |
Go deeper
- MRAM stock overview
- MRAM income statement
- MRAM valuation and score
- NVEC stock overview
- NVEC income statement
- NVEC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.